iTeos Therapeutics Statistics
Total Valuation
ITOS has a market cap or net worth of $228.02 million. The enterprise value is -$261.53 million.
Important Dates
The last earnings date was Wednesday, March 5, 2025, before market open.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ITOS has 38.19 million shares outstanding. The number of shares has increased by 13.17% in one year.
| Current Share Class | 38.19M |
| Shares Outstanding | 38.19M |
| Shares Change (YoY) | +13.17% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 0.38% |
| Owned by Institutions (%) | 67.41% |
| Float | 29.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.31 |
| Forward PS | n/a |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.62, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.62 |
| Quick Ratio | 12.35 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.07% and return on invested capital (ROIC) is -16.66%.
| Return on Equity (ROE) | -23.07% |
| Return on Assets (ROA) | -14.47% |
| Return on Invested Capital (ROIC) | -16.66% |
| Return on Capital Employed (ROCE) | -24.25% |
| Revenue Per Employee | $202,312 |
| Profits Per Employee | -$776,960 |
| Employee Count | 173 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ITOS has paid $14.07 million in taxes.
| Income Tax | 14.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.01% in the last 52 weeks. The beta is 1.38, so ITOS's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -52.01% |
| 50-Day Moving Average | 7.28 |
| 200-Day Moving Average | 10.80 |
| Relative Strength Index (RSI) | 34.47 |
| Average Volume (20 Days) | 370,316 |
Short Selling Information
The latest short interest is 1.37 million, so 3.60% of the outstanding shares have been sold short.
| Short Interest | 1.37M |
| Short Previous Month | 1.28M |
| Short % of Shares Out | 3.60% |
| Short % of Float | 4.72% |
| Short Ratio (days to cover) | 3.71 |
Income Statement
In the last 12 months, ITOS had revenue of $35.00 million and -$134.41 million in losses. Loss per share was -$3.32.
| Revenue | 35.00M |
| Gross Profit | 35.00M |
| Operating Income | -156.81M |
| Pretax Income | -102.48M |
| Net Income | -134.41M |
| EBITDA | -155.57M |
| EBIT | -156.81M |
| Loss Per Share | -$3.32 |
Full Income StatementBalance Sheet
The company has $494.65 million in cash and $5.10 million in debt, giving a net cash position of $489.55 million or $12.82 per share.
| Cash & Cash Equivalents | 494.65M |
| Total Debt | 5.10M |
| Net Cash | 489.55M |
| Net Cash Per Share | $12.82 |
| Equity (Book Value) | 590.29M |
| Book Value Per Share | 16.14 |
| Working Capital | 469.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$98.18 million and capital expenditures -$1.63 million, giving a free cash flow of -$99.81 million.
| Operating Cash Flow | -98.18M |
| Capital Expenditures | -1.63M |
| Free Cash Flow | -99.81M |
| FCF Per Share | -$2.61 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -448.03% |
| Pretax Margin | -343.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ITOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.17% |
| Shareholder Yield | -13.17% |
| Earnings Yield | -58.95% |
| FCF Yield | -43.77% |
Analyst Forecast
The average price target for ITOS is $26.00, which is 335.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.00 |
| Price Target Difference | 335.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 34.57% |
| EPS Growth Forecast (5Y) | -34.42% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ITOS has an Altman Z-Score of 2.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.88 |
| Piotroski F-Score | 2 |